Abstract
The lymphocyte proliferative response to recall antigens is lost following HIV infection. We sought to devise a means by which the functional immune status of persons in the early stages of HIV infection could be monitored quantitatively. The response to tetanus toxoid was examined in 45 HIV-infected individuals and 11 controls using conventional lymphocyte proliferative assays concurrently with limiting dilution analysis utilizing the secretion of interleukin-2 as the measure of a response. Our data show that the limiting dilution analysis detects tetanus toxoid-reactive T cells in 80% of those tested, as compared to only 44% by proliferation. However, the frequency of tetanus-reactive T cells in HIV-infected individuals (median frequency = 1/59,156) is decrease five-fold as compared to seronegative controls (median frequency = 1/11,599). Longitudinal studies demonstrated a time-dependent decrease in the frequency of tetanus-specific T cell responses in the HIV-infected individuals. Thus, the limiting dilution analysis is a quantitative approach for detecting antigen-specific T cells in HIV-infected individuals, and may be used to monitor changes in T cell function in HIV infection.
Similar content being viewed by others
References
Popovic M, Sarngadharan MG, Read E, Gallo RC: Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497–500, 1984
Lifson JD, Feinberg MB, Reyes GR, Rabin L, Banapour B, Chakrabarti S, Moss B, Wong-Staal F, Steimer KS, Engelman EG: Induction of CD4 dependent cell fusion by HTLV-III/LAV envelope glycoprotein. Nature 323:725–728, 1986
Lifson JD, Reyes GR, McGrath MS, Stein BS, Engelman EG: AIDS retrovirus induced cytopathology: Giant cell formation and involvement of CD4 antigen. Science 232:1123–1127, 1986
Sodroski J, Goh WC, Rosen C, Campbell K, Haseltine WA: Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature 322:470–474, 1986
Lyerly HK, Reed DL, Matthews TJ, Langlois AJ, Ahearne PA, Petteway JR, Weinhold KJ: Anti-gp120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC. AIDS Res Hum Retrovirus 3:409–422, 1987
Katz JD, Nishanian P, Mitsuyasu R, Bonavida B: Antibody-dependent cellular cytotoxicity (ADCC)-mediated destruction of human immunodeficiency virus (HIV)-coated CD4+ T lymphocytes by acquired immunodeficiency syndrome (AIDS) effector cells. J Clin Immunol 8:453–458, 1988
Rosenberg ZF, Fauci AS: Immunopathogenesis of HIV infection. FASEB J 5:2382–2390, 1991
Schnittman SM, Denning SM, Greenhouse JJ, Justement JS, Baseler M, Kurtzberg J, Haynes BF, Fauci AS: Evidence for susceptibility of intrathymic T-Cell precursors and their progeny carrying T-cell antigen receptor phenotypes TCRαβ+ and TCRγδ+ to human immunodeficiency virus infection: A mechanism for CD4+ (T4) lymphocyte depletion. Proc Natl Acad Sci 87:7727–7731, 1990
Hoyos B, Ballard DW, Bohnlein E, Siekevitz M, Greene WC: Kappa B-specific DNA binding proteins: Role in regulation of human interleukin-2 gene expression. Science 244:457–460, 1989
Nabel G, Baltimore D: An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711–713, 1987
Bohnlein E, Lowenthal JW, Siekevitz M, Ballard DW, Franza BR, Greene WC: The same inducible nuclear proteins regulate mitogen activation of both the interleukin-2 receptor alpha gene and type 1 HIV. Cell 53:827–836, 1988
Greene WC, Bohnlein E, Ballard DW: HIV-1, HTLV-1 and normal T cell growth: Transcriptional strategies and surprises. Immunol Today 10:272–278, 1989
Lenardo MJ, Baltimore D: NF-kB: A pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227–229, 1989
Jamieson C, McCaffrey PG, Rao A, Sen, R: Physiologic activation of T cells via the T cell receptor induces NF-kB. J Immunol 147:416–420, 1991
Lane HC, Depper JM, Greene WC, Whalen G, Waldmann TA, Fauci AS: Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome: Evidence for a selective defect in soluble antigen recognition. N Engl J Med 313:79–84, 1985
Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients: Independence of CD4+ cell numbers and clinical staging. J Clin Invest 84:1892–1899, 1989
Fauci AS: The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239:617–622, 1988
Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, Shearer GM, Berzofsky JA: Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 339:383–385, 1989
Adams PW, Opremcak EM, Orosz CG: Limiting dilution analysis of human, tetanus-reactive helper T lymphocytes: A rapid method for the enumeration of helper T lymphocytes with specificity for soluble antigens. J Immunol Methods 142:231–241, 1991
Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614–1619, 1981
Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS: Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 87:6058–6062, 1990
Shalaby MR, Krowka JF, Gregory TJ, Hirabayashi SE, McCabe SM, Kaufman DS, Stites DP, Ammann AJ: The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro. Cell Immunol 110:140–148, 1987
Weinhold KJ, Lyerly HK, Stanley SD, Austin AA, Matthews TJ, Bolognesi DP: HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J Immunol 142:3091–3097, 1989
Mann DL, Lasane F, Popovic M, Arthur LO, Robey WG, Blattner WA, Newman MJ: HTLV-III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J Immunol 138:2640–2644, 1987
Diamond DC, Sleckmann BP, Gregory T, Lasky LA, Greenstein JL, Burakoff SJ: Inhibition of CD4+ T-cell function by the HIV envelope protein, gp120. J Immunol 141:3715–3717, 1988
Rosenstein Y, Burakoff SJ, Herrmann SH: HIV-gp120 can block CD4-class II MHC-mediated adhesion. J Immunol 144:526–531, 1990
Nair MPN, Pottathil R, Heimer EP, Schwartz SA: Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: Effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc Natl Acad Sci 85:6498–6502, 1988
Schrier RD, Gnann JW, Landes R, Lockshin C, Richman D, McCutchan A, Kennedy C, Oldstone MBA, Nelson JA: T cell recognition of HIV synthetic peptides in a natural infection. J Immunol 142:1166–1176, 1989
Viscidi RP, Mayur K, Lederman HM, Frankel AD: Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Science 246:1606–1608, 1989
Shearer GM, Roilides E, Pizzo P, Clerici M: CD4+ T helper cell function is actively suppressed in HIV infection (abstract TU.A.22)In Abstract Book vol. 1, VII International Conference on AIDS. Rome, Italy, Istituto Superiore di Sanità, 1991
Gotch FM, Nixon DF, Alp N, McMichael AJ, Borysiewicz LK: High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. In Immunol 2:707–712, 1990
Hoffenbach A, Langlade-Demoye P, Dadaglio G, Vilmer E, Michel F, Mayaud C, Autran B, Plata F: Unusually high frequencies of HIV-specific cytotoxic T lymphocytes in humans. J Immunol 142:452–462, 1989
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sabbaj, S., Para, M.F., Fass, R.J. et al. Quantitation of antigen-specific immune responses in human immunodeficiency virus (HIV)-infected individuals by limiting dilution analysis. J Clin Immunol 12, 216–224 (1992). https://doi.org/10.1007/BF00918092
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918092